Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

VTYX Ventyx Biosciences Inc

2,205

0,015 (0,68%)

Zuletzt aktualisiert: 17:40:29

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Ventyx Biosciences Charts.

Ventyx Biosciences (NASDAQ:VTYX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Ventyx Biosciences Charts.

News Ventyx Biosciences Inc

Form 4 - Statement of changes in beneficial ownership of securities
Montag 30 Dezember 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 27 Dezember 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 11 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 26 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Montag 18 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Ventyx Biosciences Inc News-Artikel

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen